Navigation Links
FBR Capital Markets Hires Senior Healthcare Analyst
Date:11/2/2007

Christopher Warren to Cover Medical Devices

ARLINGTON, Va., Nov. 2 /PRNewswire-FirstCall/ -- FBR Capital Markets Corporation (Nasdaq: FBCM) (FBR Capital Markets) today announced that Christopher Warren has joined FBR Capital Markets as a Senior Vice President and Senior Research Analyst within its healthcare group and will focus on the medical device sector.

"Chris has nearly ten years of experience in equity research, and we value the disciplined, rigorous method he's developed as an analyst over that period," said David Khani, Director of Research. "We continue to expand our team of analysts, and the addition of coverage for medical device equities will complement the expertise of our healthcare group. FBR Capital Markets Research has been investing in its growth and value products and continues to expand these platforms."

Before joining FBR Capital Markets, Mr. Warren was a senior medical device analyst with SunTrust Robinson Humphrey. Prior to that, he was a senior medical device analyst with Janney Montgomery Scott. Mr. Warren began his career as an investment banking analyst at Credit Suisse First Boston.

Mr. Warren will be based in FBR Capital Markets' New York Office.

FBR Capital Markets Corporation (FBR Capital Markets), a majority-owned subsidiary of Friedman, Billings, Ramsey Group, Inc. (FBR), provides investment banking*, merger and acquisition advisory services*, institutional brokerage*, asset management and private wealth services. FBR Capital Markets focuses capital and financial expertise on eight industry sectors: consumer, diversified industrials, energy & natural resources, financial institutions, healthcare, insurance, real estate, and technology, media & telecom. FBR is headquartered in the Washington, D.C. metropolitan area with offices in Arlington, VA; Boston; Dallas; Houston; Irvine; London, England; New York; San Francisco; and Sydney, Australia. For more information, please visit http://www.fbrcapitalmarkets.com.

*Friedman, Billings, Ramsey & Co., Inc.


'/>"/>
SOURCE FBR Capital Markets Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Gay capital reeling with rising HIV infection
2. Drugs Manufacturers Capitalizing On The Surge In Demand For Bone Health Care
3. Meningitis is rocking the capital again
4. India Crowned As the Diabetic Capital
5. China Crowned the Diabetic Capital of the World
6. Low Awareness Of Kawasaki Disease In Capital: Parents Form Support Group
7. Zagreb, capital of Croatia, affected by first bird flu case
8. Chikungunya in the Capital
9. Dengue Outbreak in the Capital is not an Epidemic: Government
10. Private Health Clinics in the Capital on Strike
11. Migration is the Cause for Fresh Polio Cases in the Capital: Sheila Dikshit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... 2016 , ... Since launching its annual volunteer campaign on ... footwear industry, has broken all previous participation records in its first two weeks ... during the months of April and May, the 2016 Footwear Cares initiative is ...
(Date:4/29/2016)... ... April 29, 2016 , ... Our bodies are bombarded daily by ... and deal with these stressors is to adopt a more healthful diet, but too ... Risa Groux, a certified Holistic Nutritionist and the creator of the Newport Beach Cleanse ...
(Date:4/29/2016)... CA (PRWEB) , ... April 29, 2016 , ... ... advocating optimistic healthcare awareness and author of best seller "LOVE, MEDICINE and MIRACLES") ... Radio Monday, May 2, 2016 and podcasted thereafter . Dr. Bernie Siegel, ...
(Date:4/29/2016)... Fort Stewart, GA (PRWEB) , ... April 29, 2016 , ... ... on Monday, May 16, 2016, at its new location in the Exchange Furniture Mall ... including a raffle for a 50-inch Samsung Smart TV. Plus attendees will have the ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... team BioCellection won the $30,000 Perlman Grand Prize of the 2016 Wharton Business ... Award, the Michelson People’s Choice Award, and the Committee Award for Most ‘Wow ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... Schweiz, April 27, 2016 ... CEO Forums in Zürich gab Strekin AG ... Wirkstoffkandidaten STR001 zur Erhaltung des Resthörvermögens von ... bekannt. Für die umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe ... angeworben. STR001 wird während der Operation direkt ...
(Date:4/27/2016)... , April 27, 2016   Zillion ... its digital health technology platform, which specializes in ... programs into scalable digital products, Zillion enables companies ... and empower consumers to take control of their ... live video conferencing – including one-to-one, group and ...
(Date:4/27/2016)... 2016 Oasmia Pharmaceutical AB ... a new generation of drugs within human and ... for Paclical/Apealea in the Phase III study that ... ovarian cancer. These preliminary results showed non-inferiority between ... carboplatin versus Taxol in combination with carboplatin. In ...
Breaking Medicine Technology: